XCL1 and neoplasm: To demonstrate the on-target effects of anti-CCR3 antibody, we also evaluated the immunogenicity and anti-tumor effect of XCL1-E6E7 with XCR1 as the specific receptor in mice with or without CCR3 + cells [29].